Viral hepatitis remains a silent but urgent global health threat with millions of individuals undiagnosed or lost to follow-up. Healthcare professionals are challenged to bridge the gap between screening and treatment within vulnerable communities.
This TeleECHO series provides a comprehensive overview of current and emerging therapies for spondyloarthritis (SpA) conditions, translating the latest clinical data and guideline recommendations into practical, real-world applications for HCPs.
PI3K/AKT pathway inhibitors can lead to hyperglycemia, but you can be ready when or if it happens. Join us for this live webinar designed to elevate your skills to prevent and manage hyperglycemia in patients with metastatic HR+/HER2- breast cancer.
This live, "Ask the Expert" webinar offers the opportunity to engage directly with nationally recognized PTCL experts who will translate emerging evidence into practical guidance.
The PREPARE Summit program is an interactive, case-based educational series designed to help clinicians identify, evaluate, and manage early cognitive decline in primary care settings.
Build a compliant, profitable healthcare practice using cutting-edge strategies and tools for sustainable growth.
In this interactive session, join a multidisciplinary panel of HIV prevention and mental health experts to explore frameworks for implementation.
Embark on the path to become an expert injector! This program provides you with the knowledge and practical skills needed to succeed. Class size is limited to 8, ensuring you receive an individualized training environment. Models are provided.
Embark on the path to become an expert injector! This program provides you with the knowledge and practical skills needed to succeed. Class size is limited to 8, ensuring you receive an individualized training environment. Models are provided
Endocrine resistance remains a key challenge in ER+/HER2- metastatic breast cancer, often driven by acquired ESR1 mutations. Early detection using ctDNA-based testing is essential for optimal integration of next-generation oral SERDs.
